CLX
Clorox Company
NYSE · Consumer products
$119.36
+1.75 (+1.49%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 6.91B | 6.91B | 234.58M | 229.40M | 255.29M |
| Net Income | 788.01M | 709.28M | 20.59M | 17.12M | 20.62M |
| EPS | — | — | — | — | — |
| Profit Margin | 11.4% | 10.8% | 8.8% | 7.5% | 8.1% |
| Rev Growth | 0.0% | 0.0% | +23.0% | -9.1% | +10.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 6.40B | 6.40B | 1.38B | 1.42B | 1.39B |
| Total Equity | 814.18M | 814.18M | 6.81B | 7.47B | 7.48B |
| D/E Ratio | 7.86 | 7.86 | 0.20 | 0.19 | 0.19 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.13B | 1.07B | 31.29M | 32.85M | 33.56M |
| Free Cash Flow | — | — | 12.17M | 18.25M | 19.03M |